2024 International Colloquium on Hyperemesis Gravidarum

This application seeks funding to support attendance and presentation by those who are trainees, new investigators, or under-represented minorities at the 2024 International Colloquium on Hyperemesis Gravidarum. Hyperemesis gravidarum (HG) is a severe form of nausea and vomiting during pregnancy that affects approximately 3-10% of pregnant women, leading to significant short- and long-term

complications for both the pregnant patient and fetus. Minority populations and their offspring are disproportionately affected. This conference is designed to foster collaboration between researchers, clinicians, patients, and patient advocacy groups to further our understanding and improve the treatment of HG. We will be highlighting new research on the pathogenesis of HG with opportunities

for treatment and prevention, the impact of malnutrition and strategies to prevent it, HG challenges in low-income nations, the need for further research on health disparities, and improving equity in the treatment of patients with HG. This will be the 5th biennial international conference on HG, but the first

held in the United States. The meeting will be held over 2 days with multiple opportunities for oral and poster presentations including new investigators. Prizes will be awarded for the best oral and poster presentations by trainees. There will be breakout sessions designed to foster collaboration between

experienced researchers and new investigators along with clinicians and patients. Attendees and presenters will be able to apply for travel support and recipients will be chosen by the ICHG Scientific Committee based on their expressed need, contribution(s) to the meeting, trainee/new investigator status, identification as a member of an underrepresented minority, and/or individual with a disability

or residence in a developing country. ICHG historically has a high representation of women as both speakers and attendees (>50% speakers, >75% attendees). Minority representation has been low, so we are striving to improve representation. This grant will help to improve diversity and several sessions

will help promote more inclusive research and better equity in patient care. Our selected venue will be compliant with the Americans with Disabilities Act. There are many family-friendly activities available, and childcare options will be identified and distributed to participants. Breastfeeding infants are

welcome in the meeting, and a private room made available for breastfeeding. The result of the conference will be much-needed progress toward advancing collaboration, research, education, equity, and ultimately improved care and outcomes for this devastating pregnancy condition.